Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset (Q36788764)
Jump to navigation
Jump to search
scientific article published on 22 December 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset |
scientific article published on 22 December 2015 |
Statements
1 reference
Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset (English)
1 reference
Carla J Greenbaum
1 reference
Susanne M Cabrera
1 reference
Xujing Wang
1 reference
Yi-Guang Chen
1 reference
Shuang Jia
1 reference
Type 1 Diabetes TrialNet Canakinumab Study Group
1 reference
AIDA Study Group
1 reference
Martin J Hessner
1 reference
22 December 2015
1 reference
1 reference
1030-1046
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference